6533b823fe1ef96bd127e346

RESEARCH PRODUCT

297: Establishment of a chimeric NOD-scid/IL2RγcNull transplantation-model to evaluate graft-vs-host and graft-vs-leukemia immune responses of ex vivo modified human T lymphocyte grafts

Shamsul A. KhanM. HagemannRalf G. MeyerUdo F. HartwigL.d. ShultzThomas WehlerRupert HandgretingerChristoph HuberWolfgang HerrMarion Nonn

subject

musculoskeletal diseasesTransplantationbusiness.industryHost (biology)NodT lymphocyteHematologymedicine.diseaseVirologyTransplantationstomatognathic diseasesLeukemiaImmune systemimmune system diseaseshemic and lymphatic diseasesImmunologyMedicinebusinessEx vivo10.1016/j.bbmt.2006.12.302http://dx.doi.org/10.1016/j.bbmt.2006.12.302